Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mepolizumab for Severe Bilateral Nasal Polyposis
NCT01362244Phase 2Completed
- Sponsor
- GSK
- Start
- May 2009
- Primary completion
- Dec 2014
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 2 trial of mepolizumab in nasal polyps, sponsored by GSK. Started May 2009; status: completed.
02
Drugs
mepolizumab
03
Conditions
nasal polyps
Beyond the preview
Go deeper on NCT01362244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01362244.